➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
McKinsey
Dow
AstraZeneca
Medtronic
Mallinckrodt

Last Updated: June 19, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for HMS5552


Email this page to a colleague

« Back to Dashboard

What is the drug development status for HMS5552?

HMS5552 is an investigational drug.

There have been 13 clinical trials for HMS5552. The most recent clinical trial was a Phase 2 trial, which was initiated on August 31st 2017.

The most common disease conditions in clinical trials are Diabetes Mellitus, Type 2, Diabetes Mellitus, and [disabled in preview]. The leading clinical trial sponsors are Hua Medicine Limited, Tigermed Consulting Co., Ltd, and Covance.

There are two US patents protecting this investigational drug and fifty-two international patents.

Recent Clinical Trials for HMS5552
TitleSponsorPhase
A Clinical Study to Access the Pharmacokinetics of HMS5552 in Renal Impaired Subjects and Healthy VolunteersHua Medicine LimitedPhase 1
A Clinical Study to Access the Pharmacokinetics of HMS5552 in Hepatic Impaired Subjects and Healthy VolunteersHua Medicine LimitedPhase 1
Drug Interaction Study Between Dorzagliatin and EmpagliflozinHua Medicine LimitedPhase 1

See all HMS5552 clinical trials

Clinical Trial Summary for HMS5552

Top disease conditions for HMS5552
Top clinical trial sponsors for HMS5552

See all HMS5552 clinical trials

US Patents for HMS5552

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
HMS5552   Get Started Free Pyrrolidinone glucokinase activators Hoffmann-La Roche Inc. (Nutley, NJ)   Get Started Free
HMS5552   Get Started Free Process for the preparation of 1-([1,3]dioxolan-4-ylmethyl)-1H-pyrazol-3-ylamine HUA MEDICINE (Grand Gayman, KY)   Get Started Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for HMS5552

Drugname Country Document Number Estimated Expiration Related US Patent
HMS5552 Argentina AR071474 2028-04-16   Get Started Free
HMS5552 Austria AT557017 2028-04-16   Get Started Free
HMS5552 Australia AU2009237794 2028-04-16   Get Started Free
HMS5552 Brazil BRPI0911035 2028-04-16   Get Started Free
HMS5552 Canada CA2720524 2028-04-16   Get Started Free
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Medtronic
Johnson and Johnson
Moodys
Dow
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.